- Posted June 06, 2014
- Tweet This | Share on Facebook
Michigan, 43 states settle with GlaxoSmithKline
LANSING (AP) - A multinational drugmaker is paying Michigan, 43 other states and the District of Columbia $105 million to settle complaints that the company unlawfully marketed three drugs.
Michigan Attorney General Bill Schuette announced Wednesday that Michigan's share of the settlement is $2.6 million. The settlement resolves allegations that London-based GlaxoSmithKline illegally marketed Advair, Paxil and Wellbutrin for purposes that hadn't been approved by the Food and Drug Administration.
GSK is prohibited from disseminating information that describes any so-called off-label use.
The asthma drug Advair is Glaxo's best-selling product. Paxil and Wellbutrin are antidepressants.
Published: Fri, Jun 06, 2014
headlines Oakland County
- Affinity Bar Charity Challenge
- Rochester man sentenced for threatening judge
- State Bar to publish Member-to-Member Referral Guide
- Municipalities encouraged to review public water system settlements claims process before entering into agreements with outside firms
- Supreme Court rules against Colorado ban on 'conversion therapy' for LGBTQ+ kids
headlines National
- Techshow attendees dig deeper into AI uses and capabilities
- ACLU and BigLaw firm use ‘Orange is the New Black’ in hashtag effort to promote NY jail reform
- Where can 1Ls get five-figure signing bonuses?
- Law firms see more cyberattacks, ransomware threats, new report says
- BigLaw’s share of litigation funding dropped in 2025
- Woman faces murder charge after allegedly taking abortion medication
